Cláudio Borges Falcão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cláudio Borges Falcão has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Gandhi Rádis-Baptista
Laboratory of Biochemistry and Biotechnology, Institute for Marine Sciences, Federal University of Ceara, Fortaleza 60165-081, Brazil
11 shared publications - Ramon Róseo Paula Pessoa Bezerra de Menezes
Department of Clinical and Toxicological Analysis, Federal University of Ceará, Fortaleza, Brazil
4 shared publications Clarissa Perdigão Mello
Faculty of Pharmacy, Department of Clinical and Toxicological Analysis, Federal University of Ceará, Rua Capitão Francisco Pedro 1210, 60430-372 Fortaleza/CE, Brazil
3 shared publications- David Andreu
Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain
3 shared publications Izabel Cristina Justino Bandeira
Faculty of Pharmacy, Department of Clinical and Toxicological Analysis, Federal University of Ceará, Rua Capitão Francisco Pedro 1210, 60430-372 Fortaleza/CE, Brazil
3 shared publicationsTiago Lima Sampaio
Faculty of Medicine, Department of Pharmacology, Federal University of Ceará, Rua Coronel Nunes de Melo 1127, 60430-275 Fortaleza/CE, Brazil
3 shared publications
Latest Publications
- 18 October 2019
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 128 (2) , 414-425
The antiproliferative peptide Ctn[15‐34] is active against multidrug‐resistant yeastsCandida albicansandCryptococcus neoformans
Aims Crotalicidin (Ctn), a cathelicidin‐related antimicrobial peptide from the South American rattlesnake venom gland, and its C‐terminal Ctn[15‐34] fragment, have shown important activities against microorganisms, trypanosomatid protozoa and certain lines of tumor cells. Herein, the activity against clinical strains of fluconazole‐resistant Candida albicans and of amphotericin B and fluconazole‐resistant Cryptococcus neoformans was investigated. Methods and Results Microdilution and luminescent cell viability tests were used to evaluate and compare the susceptibility of pathogenic yeasts to these peptides. The time‐kill curves of the most active Ctn[15‐34] alone or in combination with fluconazole against drug‐resistant yeasts were determined. Concomitantly, the fungicidal and/or fungistatic effects of Ctn[15‐34] were visualized by the spotting test. The peptides were active against all strains, including those resistant to antifungals. The association of fluconazole with both Ctn and Ctn[15‐34], although not synergic, was additive. In contrast, such pattern was not observed for C. neoformans. Conclusions Overall, Ctn and Ctn[15‐34] are potential antifungal leads displaying anti‐yeast activities against clinical isolates endowed with drug resistance mechanisms. Significance and impact of the study The effective peptide activity against resistant strains of pathogenic yeasts demonstrates that crotalicidin‐derived peptides are promising templates to develop new antifungal pharmaceuticals.
- 18 October 2019
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 128 (2) , 414-425
The antiproliferative peptide Ctn[15‐34] is active against multidrug‐resistant yeastsCandida albicansandCryptococcus neoformans
Aims Crotalicidin (Ctn), a cathelicidin‐related antimicrobial peptide from the South American rattlesnake venom gland, and its C‐terminal Ctn[15‐34] fragment, have shown important activities against microorganisms, trypanosomatid protozoa and certain lines of tumor cells. Herein, the activity against clinical strains of fluconazole‐resistant Candida albicans and of amphotericin B and fluconazole‐resistant Cryptococcus neoformans was investigated. Methods and Results Microdilution and luminescent cell viability tests were used to evaluate and compare the susceptibility of pathogenic yeasts to these peptides. The time‐kill curves of the most active Ctn[15‐34] alone or in combination with fluconazole against drug‐resistant yeasts were determined. Concomitantly, the fungicidal and/or fungistatic effects of Ctn[15‐34] were visualized by the spotting test. The peptides were active against all strains, including those resistant to antifungals. The association of fluconazole with both Ctn and Ctn[15‐34], although not synergic, was additive. In contrast, such pattern was not observed for C. neoformans. Conclusions Overall, Ctn and Ctn[15‐34] are potential antifungal leads displaying anti‐yeast activities against clinical isolates endowed with drug resistance mechanisms. Significance and impact of the study The effective peptide activity against resistant strains of pathogenic yeasts demonstrates that crotalicidin‐derived peptides are promising templates to develop new antifungal pharmaceuticals.
- 10 January 2018
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 399 (2) , 187-196
The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity
The crude venom of the giant ant Dinoponera quadriceps is a cocktail of polypeptides and organic compounds that shows antiparasitic effects against Trypanosoma cruzi, the causative agent of Chagas disease. In order to investigate the venom-derived components responsible for such antitrypanosomal activity, four dinoponeratoxins (DnTxs) were identified, namely M-PONTX-Dq3a, -Dq3b, -Dq3c and -Dq4e, that are diverse in size, net charge, hydrophobicity and propensity to interact with eukaryote cell membranes. These peptides were tested against epimastigote, trypomastigote and amastigote forms of benznidazole (Bz)-resistant Y strain of T. cruzi and in mammalian host cells. The M-PONTX-Dq3a and -Dq4e inhibited all developmental forms of T. cruzi, including amastigotes, the responsible form for the maintenance of infection on chronic phase of the disease. The M-PONTX-Dq3a showed the highest selectivity index (SI) (80) and caused morphological alterations in T. cruzi, as observed by scanning electron microscopy (SEM), and induced cell death through necrosis, as seen by multiparametric flow cytometry analysis with specific biochemical markers. Altogether, the D. quadriceps venom appears as a source for the prospection of trypanocidal peptides and the M-PONTX-Dq3a arises as a candidate among the dinoponeratoxin-related peptides in the development of compounds against Chagas disease.
- 10 January 2018
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 399 (2) , 187-196
The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity
The crude venom of the giant ant Dinoponera quadriceps is a cocktail of polypeptides and organic compounds that shows antiparasitic effects against Trypanosoma cruzi, the causative agent of Chagas disease. In order to investigate the venom-derived components responsible for such antitrypanosomal activity, four dinoponeratoxins (DnTxs) were identified, namely M-PONTX-Dq3a, -Dq3b, -Dq3c and -Dq4e, that are diverse in size, net charge, hydrophobicity and propensity to interact with eukaryote cell membranes. These peptides were tested against epimastigote, trypomastigote and amastigote forms of benznidazole (Bz)-resistant Y strain of T. cruzi and in mammalian host cells. The M-PONTX-Dq3a and -Dq4e inhibited all developmental forms of T. cruzi, including amastigotes, the responsible form for the maintenance of infection on chronic phase of the disease. The M-PONTX-Dq3a showed the highest selectivity index (SI) (80) and caused morphological alterations in T. cruzi, as observed by scanning electron microscopy (SEM), and induced cell death through necrosis, as seen by multiparametric flow cytometry analysis with specific biochemical markers. Altogether, the D. quadriceps venom appears as a source for the prospection of trypanocidal peptides and the M-PONTX-Dq3a arises as a candidate among the dinoponeratoxin-related peptides in the development of compounds against Chagas disease.
- 1 January 2018
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 67 (1) , 129-138
Insights into the candidacidal mechanism of Ctn[15–34] – a carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins
Purpose. Ctn[15–34], a carboxyl-terminal fragment of crotalicidin (a cathelicidin from the venom gland of a South American rattlesnake), has shown antifungal activity against clinical and standard strains of Candida species. The aim of the present work was to investigate the underlying mechanisms of the candidicidal activity of Ctn[15–34]. Methodology. The time-kill profile and drug synergism were evaluated by means of a microdilution assay and multi-parametric flow cytometry. The presumptive interaction of Ctn[15–34] with lipid membranes was estimated in vitro with a lipid-mimic compound, the chromogenic substance 4-nitro-3-(octanoyloxy)benzoic acid (4N3OBA). Results/Key findings. The absorbance increment (at 425 nm) indicated a concentration- and time-dependent in-solution association between Ctn[15–34] and 4N3OBA. The interaction of Ctn[15-34] with Candida cells was confirmed by flow cytometric measurements with the 5(6)-carboxyfluorescein-labelled peptide (CF-Ctn[15–34]). Analysis of the killing time of Candida exposed to Ctn[15–34] and amphotericin B (AMB) showed that both the peptide and polyene drug reduce the number of c.f.u. but in mechanistically different ways. The Ctn[15–34] peptide alone caused yeast cell membrane disruption, which was confirmed by lactate dehydrogenase leakage and biomarkers of cell death mediated by necrosis. Conclusion. Overall, Ctn[15–34] displays a synergistic antifungal activity with AMB, an effect that can be further developed into a multi-target therapeutic option with other antimycotics currently in use.
- 1 January 2018
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 67 (1) , 129-138
Insights into the candidacidal mechanism of Ctn[15–34] – a carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins
Purpose. Ctn[15–34], a carboxyl-terminal fragment of crotalicidin (a cathelicidin from the venom gland of a South American rattlesnake), has shown antifungal activity against clinical and standard strains of Candida species. The aim of the present work was to investigate the underlying mechanisms of the candidicidal activity of Ctn[15–34]. Methodology. The time-kill profile and drug synergism were evaluated by means of a microdilution assay and multi-parametric flow cytometry. The presumptive interaction of Ctn[15–34] with lipid membranes was estimated in vitro with a lipid-mimic compound, the chromogenic substance 4-nitro-3-(octanoyloxy)benzoic acid (4N3OBA). Results/Key findings. The absorbance increment (at 425 nm) indicated a concentration- and time-dependent in-solution association between Ctn[15–34] and 4N3OBA. The interaction of Ctn[15-34] with Candida cells was confirmed by flow cytometric measurements with the 5(6)-carboxyfluorescein-labelled peptide (CF-Ctn[15–34]). Analysis of the killing time of Candida exposed to Ctn[15–34] and amphotericin B (AMB) showed that both the peptide and polyene drug reduce the number of c.f.u. but in mechanistically different ways. The Ctn[15–34] peptide alone caused yeast cell membrane disruption, which was confirmed by lactate dehydrogenase leakage and biomarkers of cell death mediated by necrosis. Conclusion. Overall, Ctn[15–34] displays a synergistic antifungal activity with AMB, an effect that can be further developed into a multi-target therapeutic option with other antimycotics currently in use.
- 6 December 2017
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 145 (8) , 1059-1064
Antichagasic effect of crotalicidin, a cathelicidin-like vipericidin, found in Crotalus durissus terrificus rattlesnake's venom gland
Cathelicidins are antimicrobial peptides produced by humans and animals in response to various pathogenic microbes. Crotalicidin (Ctn), a cathelicidin-related vipericidin from the South American Crotalus durissus terrificus rattlesnake's venom gland, and its fragments have demonstrated antimicrobial and antifungal activity, similarly to human cathelicidin LL-37. In order to provide templates for the development of modern trypanocidal agents, the present study evaluated the antichagasic effect of these four peptides (Ctn, Ctn[1-14], Ctn[15-34] and LL-37). Herein, Ctn and short derived peptides were tested against the epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi Y strain (benznidazole-resistant strain) and cytotoxicity in mammalian cells was evaluated against LLC-MK2 lineage cells. Ctn inhibited all T. cruzi developmental forms, including amastigotes, which is implicated in the burden of infection in the chronic phase of Chagas disease. Moreover, Ctn showed a high selective index against trypomastigote forms (>200). Ctn induced cell death in T. cruzi through necrosis, as determined by flow cytometry analyses with specific molecular probes and morphological alterations, such as loss of membrane integrity and cell shrinkage, as observed through scanning electron microscopy. Overall, Ctn seems to be a promising template for the development of antichagasic agents.
- 6 December 2017
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 145 (8) , 1059-1064
Antichagasic effect of crotalicidin, a cathelicidin-like vipericidin, found in Crotalus durissus terrificus rattlesnake's venom gland
Cathelicidins are antimicrobial peptides produced by humans and animals in response to various pathogenic microbes. Crotalicidin (Ctn), a cathelicidin-related vipericidin from the South American Crotalus durissus terrificus rattlesnake's venom gland, and its fragments have demonstrated antimicrobial and antifungal activity, similarly to human cathelicidin LL-37. In order to provide templates for the development of modern trypanocidal agents, the present study evaluated the antichagasic effect of these four peptides (Ctn, Ctn[1-14], Ctn[15-34] and LL-37). Herein, Ctn and short derived peptides were tested against the epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi Y strain (benznidazole-resistant strain) and cytotoxicity in mammalian cells was evaluated against LLC-MK2 lineage cells. Ctn inhibited all T. cruzi developmental forms, including amastigotes, which is implicated in the burden of infection in the chronic phase of Chagas disease. Moreover, Ctn showed a high selective index against trypomastigote forms (>200). Ctn induced cell death in T. cruzi through necrosis, as determined by flow cytometry analyses with specific molecular probes and morphological alterations, such as loss of membrane integrity and cell shrinkage, as observed through scanning electron microscopy. Overall, Ctn seems to be a promising template for the development of antichagasic agents.
- 16 February 2017
- Published by Springer Nature in Food and Environmental Virology
- Vol. 9 (3) , 277-286
Antiviral Activity of Ctn[15-34], A Cathelicidin-Derived Eicosapeptide, Against Infectious Myonecrosis Virus in Litopenaeus vannamei Primary Hemocyte Cultures
The shrimp farming has been converted into a mature aquaculture industry dealing with over millions of metric tonnes of processed commodities. Nevertheless, the global shrimp productions are constantly threatened by disease outbreaks, mainly triggered by rapidly disseminating viruses. Infectious myonecrosis virus (IMNV) is one of these epizootic agents affecting shrimp production in Brazil, of which no treatment exists. Herein, the antiviral activity against IMNV of an eicosapeptide, named Ctn[15-34], derived from a member of the cathelicidin family of antimicrobial peptides, was demonstrated. Cultures of hemocytes from Litopenaeus vannamei were established that support IMNV replication and infectivity titration. The cytotoxic effect of IMNV in culture and the in vitro anti-IMNV activity of Ctn[15-34] were assessed using a high-sensitive fluorescent-based method in combination with quantitative PCR. The Ctn[15-34] (<12.5 µM) neutralized the toxic effects of IMNV at loads sufficient to kill 50% of shrimp hemocytes. This study reported for the first time the replication of IMNV in vitro and the employment of a straightforward methodology to assess cell viability and viral/antiviral activities. In addition, it provided the basis for the development of the anti-infective multi-effector Ctn[15-34] eicosapeptide and analogs as components of antiviral formulations against shrimp viral diseases.
- 16 February 2017
- Published by Springer Nature in Food and Environmental Virology
- Vol. 9 (3) , 277-286
Antiviral Activity of Ctn[15-34], A Cathelicidin-Derived Eicosapeptide, Against Infectious Myonecrosis Virus in Litopenaeus vannamei Primary Hemocyte Cultures
The shrimp farming has been converted into a mature aquaculture industry dealing with over millions of metric tonnes of processed commodities. Nevertheless, the global shrimp productions are constantly threatened by disease outbreaks, mainly triggered by rapidly disseminating viruses. Infectious myonecrosis virus (IMNV) is one of these epizootic agents affecting shrimp production in Brazil, of which no treatment exists. Herein, the antiviral activity against IMNV of an eicosapeptide, named Ctn[15-34], derived from a member of the cathelicidin family of antimicrobial peptides, was demonstrated. Cultures of hemocytes from Litopenaeus vannamei were established that support IMNV replication and infectivity titration. The cytotoxic effect of IMNV in culture and the in vitro anti-IMNV activity of Ctn[15-34] were assessed using a high-sensitive fluorescent-based method in combination with quantitative PCR. The Ctn[15-34] (<12.5 µM) neutralized the toxic effects of IMNV at loads sufficient to kill 50% of shrimp hemocytes. This study reported for the first time the replication of IMNV in vitro and the employment of a straightforward methodology to assess cell viability and viral/antiviral activities. In addition, it provided the basis for the development of the anti-infective multi-effector Ctn[15-34] eicosapeptide and analogs as components of antiviral formulations against shrimp viral diseases.
- 23 November 2016
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 70 (3) , 231-237
Anti-fungal activity of Ctn[15–34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin
Journal of Antibiotics, official journal of the Japan Antibiotics Research Association, is a print and online publication that focuses on research on antibiotics and related types of medicinal substances
- 23 November 2016
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 70 (3) , 231-237
Anti-fungal activity of Ctn[15–34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin
Journal of Antibiotics, official journal of the Japan Antibiotics Research Association, is a print and online publication that focuses on research on antibiotics and related types of medicinal substances
- 26 October 2015
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (21) , 8553-8563
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity
In silico dissection of crotalicidin (Ctn), a cathelicidin from a South American pit viper, yielded fragments Ctn[1–14] and Ctn[15–34], which were tested to ascertain to what extent they reproduced the structure and activity of the parent peptide. NMR data showing Ctn to be α-helical at the N-terminus and unstructured at the C-terminus were matched by similar data from the fragments. The peptides were tested against Gram-positive and -negative bacteria and for toxicity against both tumor and healthy cells. Despite its amphipathic α-helical structure, Ctn[1–14] was totally inert toward bacteria or eukaryotic cells. In contrast, unstructured Ctn[15–34] replicated the activity of parent Ctn against Gram-negative bacteria and tumor cells while being significantly less toxic toward eukaryotic cells. This selectivity for bacteria and tumor cells, plus a stability to serum well above that of Ctn, portrays Ctn[15–34] as an appealing candidate for further development as an anti-infective or antitumor lead.
- 26 October 2015
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (21) , 8553-8563
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity
In silico dissection of crotalicidin (Ctn), a cathelicidin from a South American pit viper, yielded fragments Ctn[1–14] and Ctn[15–34], which were tested to ascertain to what extent they reproduced the structure and activity of the parent peptide. NMR data showing Ctn to be α-helical at the N-terminus and unstructured at the C-terminus were matched by similar data from the fragments. The peptides were tested against Gram-positive and -negative bacteria and for toxicity against both tumor and healthy cells. Despite its amphipathic α-helical structure, Ctn[1–14] was totally inert toward bacteria or eukaryotic cells. In contrast, unstructured Ctn[15–34] replicated the activity of parent Ctn against Gram-negative bacteria and tumor cells while being significantly less toxic toward eukaryotic cells. This selectivity for bacteria and tumor cells, plus a stability to serum well above that of Ctn, portrays Ctn[15–34] as an appealing candidate for further development as an anti-infective or antitumor lead.
- 1 June 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1850 (6) , 1253-1260
Rhodamine B-conjugated encrypted vipericidin nonapeptide is a potent toxin to zebrafish and associated with in vitro cytotoxicity
- 1 June 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1850 (6) , 1253-1260
Rhodamine B-conjugated encrypted vipericidin nonapeptide is a potent toxin to zebrafish and associated with in vitro cytotoxicity